Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in the PLATO Study

Overview of attention for article published in Circulation, December 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

policy: 2 policy sources
twitter: 15 X users

facebook: 3 Facebook pages
guideline: 1 clinical guideline source

Readers on

mendeley: 133 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 16 X posts from 15 X users, with an upper bound of 97,419 followers.

Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in PLATO http://t.co/1ZwHFRQKzR

Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in PLATO http://t.co/KTx8ZBp4gO

Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in PLATO http://t.co/Y3MdD15Xa1

Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in the PLATO Study http://t.co/Fvgp9NgN

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 12 additional X posts.